Stock Notes

Cipla

Every Finvezto stock note on Cipla, dated and newest first. Coverage spans pharma.

1 note and counting
23 Jul 2026
Cipla's June quarter net profit fell 39 percent to 789 crore rupees, its third straight quarterly decline.
Operating margin dropped to 16.7 percent from 25.6 percent as raw-material costs rose 22.8 percent. North America revenue slid to 162 million dollars from 226 million a year earlier. Revenue edged up just 2 percent to 7,119 crore rupees, below what the street expected.
Finvezto Membership

Get the research behind the notes

Stock notes are the free daily layer. The membership carries the full Flexi-Wealth system: an ETF core portfolio with monthly rebalancing signals, fifteen quality-momentum stocks with exact weightages every month, options income and hedging recommendations, and the institutional data toolkit. One flat membership covers everything.

Become a Member Read free sample research →

Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630. Stock notes are market commentary for general information and education. They are not investment advice, not a recommendation to buy or sell, and do not account for any individual's financial situation. Investment in securities is subject to market risks. Please read all related documents carefully before investing. Past performance is not a guarantee of future results.